PORTLAND, Oregon, September 24, 2018 /PRNewswire/ --
Rise in prevalence of diabetes, surge in obese & geriatric population, sedentary lifestyle, and technological advancements in diabetes devices would drive the growth of the global self-monitoring blood glucose devices market.
Allied Market Research published a report, titled, "Self-Monitoring Blood Glucose Devices Market by Product (Test Strips, Lancets, and Blood Glucose Meters), Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), and End User (Hospital, Home Settings, and Diagnostic Centers): Global Opportunity Analysis and Industry Forecast, 2018-2025." The report offers insights on major market segments, top investment pockets, key player positioning, drivers & opportunities, and strategic developments in the industry. According to the report, the global self-monitoring blood glucose devices market garnered $7.76 billion in 2017 and is projected to reach $10.82 billion through 2025, growing at a CAGR of 4.2% from 2018 to 2025.
Rise in prevalence of diabetes, increase in obese and geriatric population, sedentary lifestyle, technological advancements in diabetes devices, and increased need for faster, safer diagnosis and treatment of diabetes drive the growth of the global self-monitoring blood glucose devices market. However, inability of blood glucose monitoring devices to measure the exact level of glucose and adverse effects associated with some of the diabetes care devices hinder the market growth. Conversely, rise in awareness about diabetes monitoring devices as well as high potential in untapped markets in emerging economies are expected to provide lucrative growth opportunities for the market growth.
Request A Sample at: https://www.alliedmarketresearch.com/request-sample/4149
Test strips product segment to retain its lion's share through 2025
Among products, the test strips segment captured 81% of the total market share in 2017 and would maintain its lion's share throughout the study period. This is due to the widespread availability of test strips and cost-effective nature of these products. However, the lancets segment is expected to grow at the fastest CAGR of 6.2% from 2018 to 2025. The blood glucose meters segment is expected to grow at a steady rate during the forecast period.
Type 2 diabetes application segment to be lucrative through the study period
The type 2 diabetes segment accounted for three-fourths of the total market share in 2017 and is expected to maintain its dominance through 2025. The segment is expected to grow at the fastest CAGR of 4.4% during the forecast period, as it is the most prevalent form of diabetes, which affects a greater percentage of the population. The other applications analyzed in the study are type 1 diabetes and gestational diabetes.
Home settings end user segment to capture the highest share and grow at the fastest rate
Among end users, the hospitals segment held 41% of the total market share in 2017 and would maintain its highest share by 2025, registering the fastest CAGR of 4.9% during the forecast period. This is attributed to the advent of portable, user-friendly glucose meters that can be used at home. The diagnostic centers segment is expected to grow at a steady rate during the forecast period.
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/4149
North America to be dominant, Asia-Pacific to grow the fastest
North America accounted for 40% of the total market share in 2017 and would maintain its lead position through 2025. This is attributed to factors such as new product launches, increased adoption of advanced glucose meters, and large obese population in the region. However, Asia-Pacific would grow at the fastest CAGR of 5.5% during the forecast period owing to the rapidly changing healthcare infrastructure in developing counties such as India and China, growth of medical tourism industry, rise in number of diabetes cases, increase in awareness of diabetes management, and boost in per capita income. The other regions analyzed in the report include Europe and Latin America, Middle East & Africa (LAMEA).
Frontrunners of the industry
The key market players analyzed in the research report include Abbott Laboratories, Becton, Dickinson and Company, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Medtronic plc, PHC Holdings Corporation, Sanofi S.A., Terumo Corporation, and Trividia Health, Inc.
Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree
Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
SOURCE Allied Market Research